Buy or sell Genome Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Genome Medical Stock

Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.

About Genome Medical Stock

Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. The company was founded in 2016 and is based in South San Francisco, California, United States.

Funding History

November 2016$400K
May 2017$12.0M
January 2018$11.0M
June 2019$23.0M
July 2020$325K
July 2020$14.0M
August 2021$60.0M

Management

Co-Founder & CEO

Lisa Alderson

Co-Founder

Robert Green

Board Member

Stephen Bloch

Board of Directors

Jill Davies

Board Observer

Keith Figlioli

Echo Health Ventures, Board Member Genome Medical

Jessica Zeaske

Board of Directors

Shaun Rodriguez

CMO

Steven Bleyl

CSO & VP

Hunt Willard

Board Member

Jessica Zeaske

Board of Directors

Eli Casdin

Co-Founder & Chairman

Randy Scott

Board Member | Chair Compensation | Audit | Committee | Start-Up Investor | Genome | Medicine

Timothy F.Howe

Advisor

Todd Meyerrose

Board Member

Nicholas J. Naclerio

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo